GPT and fatty liver disease: It has been observed that a low n-6/n-3 PUFA ratio (4:1) leads to a reduction in ALT, triglycerides, LDL-cholesterol, and an improvement in whole-body insulin sensitivity, favouring the reversion of fatty liver disease [50].